SAN FRANCISCO, July 31, 2018 /PRNewswire/ -- The global kidney cancer drugs market size is expected to be valued at USD 6.3 billion by 2022, as per a new report by Grand View Research, Inc., registering a CAGR of 5.4% during the forecast period. Market growth is largely driven by facto...
from PR Newswire: //https://ift.tt/2v5oY7n
No comments:
Post a Comment